Skip to main content
. 2021 Aug 31;14:3509–3518. doi: 10.2147/IDR.S325520

Table 1.

In vitro Activity of Imipenem/Relebactam and Imipenem Against P. Aeruginosa and A. Baumannii Collected in China from 2015 to 2018

Organism/Antimicrobial Agent MIC (mg/L) MIC Interpretation
MIC50 MIC90 MIC Range Susceptible Rate (%) Intermediate Rate (%) Resistant Rate (%)
P. aeruginosa (N = 1886)
Imipenem/relebactam 0.5 8 < 0.6 to > 32 84.2 5.0 10.8
Imipenem 2 32 < 0.12 to > 32 55.7 6.2 38.1
Imipenem-non-susceptible P. aeruginosa (N = 835)
Imipenem/relebactam 2 > 32 0.25 to > 32 64.4 11.1 24.4
Imipenem 16 > 32 4 to > 32 0.0 13.9 86.1
MDR P. aeruginosa (N = 835)
Imipenem/relebactam 2 > 32 < 0.06 to > 32 65.8 10.2 24.1
Imipenem 16 > 32 0.25 to > 32 25.2 6.7 68.1
A. baumannii (N = 1889)
Imipenem/relebactam 32 > 32 < 0.06 to > 32 22.2 0.6 77.2
Imipenem 32 > 32 < 0.12 to > 32 21.0 0.5 78.6
Imipenem-non-susceptible A. baumannii (N = 1493)
Imipenem/relebactam 32 > 32 0.25 to > 32 1.8 0.7 97.5
Imipenem 32 > 32 4 to > 32 0.0 0.6 99.4
MDR A. baumannii (N = 1547)
Imipenem/relebactam 32 > 32 < 0.06 to >32 5.3 0.7 94.1
Imipenem 32 > 32 0.25 to > 32 4.0 0.4 95.6

Abbreviations: MIC, minimum inhibitory concentrations; MDR, multidrug resistance.